Direkt zum InhaltDirekt zur SucheDirekt zur Navigation
▼ Zielgruppen ▼


TaNeDS Global 2019

The Deadline of Submission is February 15, 2019

TaNeDS program provides close partnership between you and scientists in Daiichi Sankyo to tackle unmet medical needs.

The program is open to principal investigators affiliated with research institution in academia and small biotech located in Europe and the United States.


What is TaNeDS?

TaNeDS (Take a New Challenge for Drug diScovery) is Daiichi Sankyo's open competition grant program. To help realize our corporate philosophy – "Passion for Innovation. Compassion for Patients." –this program serves as an interactive platform that gathers and nurtures the wisdom of researchers from diverse scientific backgrounds.

Initially launched in Japan in 2011 and in Europe in 2013, the goal of this program is to generate breakthrough pharmaceutical drugs for human health by promoting new drug discovery themes, R&D technologies, and continuous collaboration with external researchers and research groups.

In this program, we provide Our Research Interests and collect Application Forms from principal investigators affiliated with research institution in academia and small biotech. After careful review by selected members of Daiichi Sankyo, we start the collaboration research with the winners of this program.

In 2019, this program will cover the European area and all across the United States. We set two sizes of the grant, up to €/$ 75,000 per year (Type A) for discovery stage and up to €/$150,000 per year (Type B) for validation stage.


Our Research Interests

  • Oncology

  • Pain / Neuroscience

  • Cardiovascular and renal diseases

  • Rare diseases

  • Other diseases

  • Cell therapy


Please follow this link for more information on the programme or Daiichi Sankyo.